Protective immunity provided by a new modified SERA protein peptide: Its immunogenetic characteristics and correlation with 3D structure
The serine repeat antigen (SERA) protein is a leading candidate molecule for inclusion as a component in a multi-antigen, multi-stage, minimal subunit-based, chemically synthesised anti-malarial vaccine. Peptides having high red blood cell binding affinity (known as HABPs) have been identified in th...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2012
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/24252
- Acceso en línea:
- https://doi.org/10.1007/s00726-011-1061-5
https://repository.urosario.edu.co/handle/10336/24252
- Palabra clave:
- Malaria vaccine
Peptide derivative
Serine repeat antigen protein derivative
Unclassified drug
Amino acid sequence
Amino acid substitution
Animal experiment
Antibody production
Article
Binding affinity
Carboxy terminal sequence
Controlled study
Erythrocyte
Haplorhini
Immunity
Immunogenicity
Malaria falciparum
Molecular model
Nonhuman
Plasmodium falciparum
Priority journal
Protein structure
Proton nuclear magnetic resonance
Three dimensional imaging
Amino acid sequence
Animals
Aotidae
Erythrocytes
Malaria vaccines
Molecular sequence data
Plasmodium falciparum
Plasmodium falciparum
Malaria vaccine
Nmr
Sera 5
Structure
molecular
protozoan
falciparum
amino acid
Antigens
Malaria
Models
Repetitive sequences
- Rights
- License
- Abierto (Texto Completo)
Summary: | The serine repeat antigen (SERA) protein is a leading candidate molecule for inclusion as a component in a multi-antigen, multi-stage, minimal subunit-based, chemically synthesised anti-malarial vaccine. Peptides having high red blood cell binding affinity (known as HABPs) have been identified in this protein. The 6733 HABP was located in the C-terminal portion of the 47-kDa fragment while HABP 6754 was located in the C-terminal region of the 56-kDa fragment. These conserved HABPs failed to induce an immune response. Critical red blood cell binding residues and/or their neighbours (assessed by glycine-analogue scanning) were replaced by others having the same mass, volume and surface but different polarity, rendering some of them highly immunogenic when assessed by antibody production against the parasite or its proteins and protection-inducers against experimental challenge with a highly infectious Aotus monkey-adapted Plasmodium falciparum strain. This manuscript presents some modified HABPs as vaccine candidate components for enriching our tailor-made anti-malarial vaccine repertoire, as well as their 3D structure obtained by 1H-NMR displaying a short-structured region, differently from the native ones having random structures. © 2011 Springer-Verlag. |
---|